Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

CUSIP: 603170101

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+7,506,057
Put/Call ratio
190%
SEC-reported price per share
$36.29
Number of holders
223
Value change
+$270,032,812
Number of buys
129
Open additional details 1 more signal available
Number of sells
90
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
79,235,030

Security key

603170101

Report period

Q4 2025

Institutions

223

Top holders

10

Ownership snapshot

Top reported holders of MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Catalys Pacific Fund, LP
Disclosed value leader
Catalys Pacific, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 10% 13D/G row: Catalys Pacific Fund, LP Showing 1-6 of 15 holder rows.

Quick read

Catalys Pacific Fund, LP leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Catalys Pacific Fund, LP's linked filing trail.
Comparable ownership Top 5
Catalys Pacific Fund, LP 10%
RA CAPITAL MANAGEMENT, L.P. 9.9%
Samsara BioCapital, L.P. 8.2%
FMR LLC 6.3%
BlackRock, Inc. 5.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Catalys Pacific Fund, LP
13D/G
10%
$267,051,367
8,002,738 shares
-$32,576,328 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
9.9%
from 13D/G
$277,716,600
7,323,750 shares
30 Sep 2025
Samsara BioCapital, L.P.
13D/G
Srinivas Akkaraju
8.2%
$85,419,771
6,346,194 shares
+$8,209,106 04 Sep 2025
FMR LLC
13D/G 13F
Company
6.3%
$182,087,409
5,017,509 shares
$0 31 Dec 2025
BlackRock, Inc.
13D/G 13F
Company
5.2%
$149,286,258
4,113,657 shares
$0 31 Dec 2025
Andera Partners
13D/G
4.2%
$39,747,075
2,765,976 shares
$0 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
223
Shares
88,390,661
Rows available
223
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
191
Q4 2025 holders
223
Holder diff
32
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .